Amanda
Fernández Rodríguez
Instituto de Investigación Sanitaria Gregorio Marañón
Madrid, EspañaPublikationen in Zusammenarbeit mit Forschern von Instituto de Investigación Sanitaria Gregorio Marañón (33)
2024
-
Plasma metabolomic profile is near-normal in people with HIV on long-term suppressive antiretroviral therapy
Frontiers in Cellular and Infection Microbiology, Vol. 14
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Corrigendum to “PBMCs gene expression signature of advanced cirrhosis with high risk for clinically significant portal hypertension in HIV/HCV coinfected patients: A cross-control study” [Biomed. Pharmacother. 159 (2023) 114220] (Biomedicine & Pharmacotherapy (2023) 159, (S0753332223000082), (10.1016/j.biopha.2023.114220))
Biomedicine and Pharmacotherapy
-
Diagnostic Performance of the HCV Core Antigen Test To Identify Hepatitis C in HIV-Infected Patients: a Systematic Review and Meta-Analysis
Journal of clinical microbiology, Vol. 61, Núm. 1, pp. e0133122
-
Diagnostic performance of hepatitis C core antigen assay to identify active infections: A systematic review and meta-analysis
Reviews in Medical Virology, Vol. 33, Núm. 3
-
IL7RA rs10491434 polymorphism is related to spontaneous HIV infection control in naïve HIV-infected patients: A retrospective study
Journal of Medical Virology, Vol. 95, Núm. 11
-
IRF5-TNOP3 polymorphisms are associated with elite control of HIV infection: A retrospective study
Journal of medical virology, Vol. 95, Núm. 6, pp. e28841
-
Immunological and senescence biomarker profiles in patients after spontaneous clearance of hepatitis C virus: gender implications for long-term health risk
Immunity and Ageing, Vol. 20, Núm. 1
-
PBMCs gene expression signature of advanced cirrhosis with high risk for clinically significant portal hypertension in HIV/HCV coinfected patients: A cross-control study
Biomedicine and Pharmacotherapy, Vol. 159
-
Predictive plasma biomarkers of long-term increase in hepatic steatosis index after HCV eradication in HIV/HCV-coinfected patients
Biomedicine and Pharmacotherapy, Vol. 164
2022
-
Blood microbiome is associated with changes in portal hypertension after successful direct-acting antiviral therapy in patients with HCV-related cirrhosis
The Journal of antimicrobial chemotherapy, Vol. 77, Núm. 3, pp. 719-726
-
Meta-analysis: diagnostic accuracy of hepatitis C core antigen detection during therapy with direct-acting antivirals
Alimentary Pharmacology and Therapeutics, Vol. 56, Núm. 8, pp. 1224-1234
-
Metabolomic changes after DAAs therapy are related to the improvement of cirrhosis and inflammation in HIV/HCV-coinfected patients
Biomedicine and Pharmacotherapy, Vol. 147
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
-
Plasma miRNA profile at COVID-19 onset predicts severity status and mortality
Emerging microbes & infections, Vol. 11, Núm. 1, pp. 676-688
2021
2020
-
Brief Report: CYP27B1 rs10877012 T Allele Was Linked to Non-AIDS Progression in ART-Naïve HIV-Infected Patients: A Retrospective Study
Journal of acquired immune deficiency syndromes (1999), Vol. 85, Núm. 5, pp. 659-664
-
Plasma metabolomic fingerprint of advanced cirrhosis stages among HIV/HCV-coinfected and HCV-monoinfected patients
Liver International, Vol. 40, Núm. 9, pp. 2215-2227
2019
-
DBP rs16846876 and rs12512631 polymorphisms are associated with progression to AIDS naïve HIV-infected patients: A retrospective study
Journal of Biomedical Science, Vol. 26, Núm. 1
-
Genetic variants upstream of TNFAIP3 in the 6q23 region are associated with liver disease severity in HIV/HCV-coinfected patients: A cross-sectional study
Infection, Genetics and Evolution, Vol. 67, pp. 112-120